Paediatric Eczema

  • $60.00 incl. GST for PSNZ members
  • $180.00 incl. GST for non-members
Login to Purchase

About the product

Go to Registration page

Childhood eczema can be a challenging condition to manage, but pharmacists can play a vital role in supporting parents and caregivers with appropriate treatment and management.

Improve your knowledge and understanding of the challenges associated with childhood eczema and how you can support families by providing fundamental advice on the treatments available including the appropriate use of emollients and topical corticosteroids.

About this learning module

This learning consists of a presentation on demand, supplementary resources, discussion points and a reflective template to help you use this education to improve everyday practice.

This learning activity has been accredited by PSNZ Education (Professional Development and Training) for 1 hour of professional learning and is suitable for inclusion in a pharmacist’s records for Continuing Professional Development (CPD) purposes.

This course is not formally assessed.

This learning can be used for your annual recertification requirements -

This learning is suitable for all Pharmacy staff.

Presented By

Dr Diana Purvis - Paediatric Dermatologist, Starship Children’s Hospital and Auckland Dermatology

Dr Purvis was trained in New Zealand and the UK, with two years specialising in paediatric dermatology at the Great Ormond Street Hospital for Sick Children in London. As well as her expertise in children’s skin diseases and birthmarks, she is also proficient in adult skin problems including neo-natal and pregnancy-associated skin disorders. She is involved with both the Starship Children’s Hospital and teaches at the University of Auckland Medical School.

Pharmacists who complete this learning activity will be able to:

  • Recognise the common presentations of eczema
  • Describe the underlying skin barrier and inflammatory factors causing eczema
  • Explain the association between eczema and other atopic diseases
  • Compare topical steroid and calcineurin medications available in Aotearoa New Zealand
  • Explain the safe use of topical steroids for eczema
  • Explain the role of moisturisers and wash products in eczema
  • Describe how to advise patients on personal care strategies to minimize triggers for eczema
  • Discuss treatments shown not to be helpful for eczema
  • Discuss systemic agents currently available and in the pipeline for eczema treatment
  • Recognise presentations of eczema requiring referral for medical assessment

Register now